SWOG clinical trial number
C9687

The Role of Salvage Prostatectomy for Radiation Failure in Prostate Cancer.

Closed
Phase
Abbreviated Title
Local Prostate
Activated
07/01/2000
Closed
02/15/2003
Participants
NCORP, Members, UCOP, Medical Oncologists, Radiation Oncologists, Surgeons, Pathologists

Research committees

Genitourinary Cancer

Eligibility Criteria Expand/Collapse

Pts must have biopsy proven persistence or recurrence of prostate cancer with no evidence of metastatic disease at the time of biopsy. Pts must have a PS of 0-1. Pts must have been treated with >/= 60 cGy external beam RT or brachytherapy for clinical states T1-2, NX, M0 PC w/PSA < / = to 30 ng/ml prior to RT. It must be > / = 18 mos since last RT and > / = to 3 mos since last adj hormonal tx. Pts dx'ed w/another malignancy w/in previous 5 years (except for non-melanoma skin ca or Ta bladder ca) are not eligible. Pts must have a PSA of < / = 20 ng/ml obtained within 30 days prior to registration.

Other Clinical Trials

SWOG Clinical Trial Number
S2312
SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"

Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
7%
Open
Phase
SWOG Clinical Trial Number
S2200